E
Elena Valassi
Researcher at Autonomous University of Barcelona
Publications - 95
Citations - 3427
Elena Valassi is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 25, co-authored 77 publications receiving 2814 citations. Previous affiliations of Elena Valassi include Harvard University & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Neuroendocrine control of food intake.
TL;DR: The present work reviews the most recent insights into the complex and redundant molecular mechanisms regulating food intake, focusing on the most encouraging perspectives for the treatment of obesity.
Journal ArticleDOI
Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.
Nelly Pitteloud,Megan Hardin,Andrew A. Dwyer,Elena Valassi,Maria A Yialamas,Dariush Elahi,Dariush Elahi,Frances J. Hayes +7 more
TL;DR: It is concluded that insulin resistance is associated with a decrease in Leydig cell T secretion in men with a spectrum of insulin sensitivity.
Journal ArticleDOI
The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics
Elena Valassi,Alicia Santos,Maria Yaneva,Miklós Tóth,Christian J. Strasburger,Philippe Chanson,John Wass,Olivier Chabre,Marija Pfeifer,Richard A Feelders,Stylianos Tsagarakis,Peter J Trainer,Holger Franz,Kathrin Zopf,Sabina Zacharieva,Steven W. J. Lamberts,Antoine Tabarin,Susan M. Webb +17 more
TL;DR: The ERCUSYN project demonstrates a heterogeneous clinical presentation of CS at a European level, depending on gender and aetiology.
Journal ArticleDOI
Delayed Remission after Transsphenoidal Surgery in Patients with Cushing's Disease
Elena Valassi,Beverly M. K. Biller,Brooke Swearingen,Francesca Pecori Giraldi,Marco Losa,Pietro Mortini,Douglas Hayden,Francesco Cavagnini,Anne Klibanski +8 more
TL;DR: Hormonal assessment in the immediate postoperative period after TSS for CD may be misleading because delayed remission can occur in a subset of patients.
Journal ArticleDOI
Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia
TL;DR: Although most reports do not show an association between use of dopamine agonists and valvulopathy, caution must be exercised, especially in patients requiring long-term, high-dose medication regimens, Clinicians should recommend the lowest possible doses of dopamine receptors and address the question of echocardiographic monitoring on an individual basis.